Eli Lilly | LLY - Capital Ordinário

Preço das Ações
989.12
Mudança Diária
4.04 0.41%
Mensal
-4.53%
Anual
19.93%
Q1 Previsão
955.33




Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Abbott USD 1.74B 23.39B 2025-09
ALKERMES USD 165.61M 503K 2025-12
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Coherus Biosciences USD 12K 0 2025-03
Drreddys Laboratories INR 832.57M 53K 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Glaxosmithkline GBP 4.03B 2.68B 2025-09
J&J USD 2.41B 584K 2025-09
Medtronic USD 1.28B 116K 2025-09
Merck USD 2.49B 15.79M 2025-09
Neurocrine Biosciences USD 100.1M 400K 2025-12
Novartis USD 1.94B 23.4M 2025-06
Novartis USD 1.92B 17.06M 2025-09
Novo Nordisk DKK 4.44B 0 2025-12
Perrigo USD 137.6M 0 2025-12
Pfizer USD 5.69B 1000K 2025-09
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 48.08M 47.52M 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
United Therapeutics USD 43.64M 740K 2025-12
Zoetis USD 424.93M 16.54M 2025-12